Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...

One of the most confusing problems in cancer treatment is that the same drug can work very well for one person but not work ...

When "Dilbert" creator Scott Adams recently made a public plea for help accessing a life-extending cancer treatment, the story drew national attention — and sparked some questions about the drug ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a campaign by a patient and a charity. Abiraterone has been provided on the NHS ...

Vir Biotechnology has reported positive updated Phase 1 results for VIR-5500, an experimental pill-form therapy targeting metastatic prostate cancer that researchers have called “stunning.” The drug, ...

For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after NHS chiefs widened access to the treatment. Around 2,000 men diagnosed ...

Camcevi ETM, a long-acting injectable, is FDA-approved for advanced prostate cancer, showing 97.9% efficacy in testosterone suppression in a phase 3 study. Common side effects include hot flushing and ...

A major study of nearly 19,000 men has found that a baldness drug significantly cut the risk of prostate cancer, but its side effects may keep many from using it to prevent what has become the second ...

A Brit has become the first patient in Europe to trial a pioneering antibody drug that "attaches" to cancer cells. Brian Holmes, 70, has suffered from metastatic prostate cancer for two years and has ...

Taking one-fourth the standard dose of a widely used drug for prostate cancer with a low-fat breakfast can be as effective - and four times less expensive - as taking the standard dose as recommended: ...